Biolab Studies COVID-19 Strains and Aggressiveness in Jordan in Cooperation With the American Scripps Research Institute

Press release
Published April 6th, 2020 - 10:33 GMT
Biolab Studies COVID-19 Strains and Aggressiveness in Jordan in Cooperation With the American Scripps Research Institute
This step will contribute in making informed decisions and take necessary health measures to prevent the outbreak of the aggressive virus strains in the Kingdom.
Highlights
Biolab has collaborated with the American SCRIPPS Research Institute to send positive samples of the coronavirus

As part of the joint efforts between the Jordanian Ministry of Health and Biolab in exploring the Coronavirus (COVID-19) Pandemic strains, Biolab has collaborated with the American SCRIPPS Research Institute to send positive samples of the coronavirus to the institute in order to determine the aggressiveness of this virus among detected cases in the Kingdom. This step will contribute in making informed decisions and take necessary health measures to prevent the outbreak of the aggressive virus strains in the Kingdom.

Biolab Founder and CEO and immunologist, Dr. Amid Abdelnour, said: “This study will help us better interpret the significant variations in the clinical outcomes of virus carriers, and understand the difference between the infected healthy people with high immunity compared to the infected elderly and chronic disease patients. Biolab sent positive samples from the detected cases in Jordan to the American SCRIPPS Research Institute following the approval of the American Center for Disease Control and Prevention and the Jordanian Ministry of Health. The samples and strains will then be analyzed as soon as possible and will be compared with the results of other countries around the world.”

In this context, Biolab Immunologist and Head of Research and Scientific Development Department, Dr. Issa Abu Dayyeh emphasized that the genetic variations of the virus will contribute in understanding the factors that contribute to blocking the entrance of the virus into human cells, thus determining who will be able to resist the virus and who won’t.

As a regional pioneer in the field of medical diagnostics and laboratory testing, Biolab provides an extensive portfolio of more than 700 diagnostic services, catering to individuals, physicians, hospitals, and other laboratories across the Middle East. In Jordan, Biolab operates a total of 18 branches, in key locations throughout Amman – such as Al Khalidi Street, Fifth Circle, Hay Al-Yasmeen, Marj Al-Hamam, Khalda, City Mall, Bayader-Wadi Seer, Shmeisani, Third Circle, Tila’ Al Ali, Jubeiha, Moqabalein, in addition to locations outside the capital Amman namely Fuheis and Irbid. Biolab offers its patients and customers the convenience of receiving their test results online at www.biolab.jo and via its advanced mobile application.

Along with its ISO 15189 certification provided by the Jordanian Accreditation System (JAS) for quality health services, Biolab’s medical diagnostic services are accredited by the Jordanian Ministry of Health, the Joint Commission International (JCI), and the College of American Pathologists (CAP). Biolab has recently obtained accreditation from the Health Care Accreditation Council (HCAC) and is now the only stand-alone laboratory in the region that is endorsed by four international accreditation bodies.

For inquiries, please contact: …….

Background Information

Biolab

Biolab is a group of medical diagnostic laboratories that offer a full range of laboratory services in Jordan. Recognized for our innovation, quality, and convenience, biolab delivers timely, accurate results for improved patient care. Our mandate is to provide high quality, cost-effective laboratory operation through a consolidated service delivery model consisting of: one centralized laboratory and twelve specialty testing laboratories.

Check out our PR service


Signal PressWire is the world’s largest independent Middle East PR distribution service.

Subscribe

Sign up to our newsletter for exclusive updates and enhanced content